Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Invega“
Suchtreffer
Begriffe & Kennungen
Invega · 4.5 · Potential for INVEGA to affect other medicines Paliperidone is not expected to cause clinically important phar
Eintrag öffnenInvega · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenInvega · 4.8 Undesirable effects · 1
Eintrag öffnenInvega · 4.8 · 10 Hepatobiliary transaminases gamma-glutamyltran jaundice disorders increased sferase increased, hepatic enzy
Eintrag öffnenInvega · 4.8 · 11 Description of selected adverse reactions Extrapyramidal symptoms (EPS) In schizophrenia clinical trials, t
Eintrag öffnenInvega · 4.8 · 12 following ADRs that were reported more frequently in adolescents receiving INVEGA than adults receiving INV
Eintrag öffnenInvega · 4.8 · 9 Endocrine hyperprolactinaemia inappropriate disorders a antidiuretic hormone secretionc, glucose urine prese
Eintrag öffnenInvega · 4.8 · Adults Summary of the safety profile The adverse drug reactions (ADRs) most frequently reported in clinical tr
Eintrag öffnenInvega · 4.8 · Class effects QT prolongation, ventricular arrythmias (ventricular fibrillation, ventricular tachycardia), sud
Eintrag öffnenInvega · 4.8 · EPS included a pooled analysis of the following terms: Parkinsonism (includes salivary hypersecretion, musculo
Eintrag öffnenInvega · 4.8 · Elderly In a study conducted in elderly subjects with schizophrenia, the safety profile was similar to that se
Eintrag öffnenInvega · 4.8 · Extrapyramidal Symptoms (EPS) In the short-term, placebo-controlled, fixed-dose adolescent study, the incidenc
Eintrag öffnenInvega · 4.8 · Hyperprolactinaemia In schizophrenia clinical trials, increases in serum prolactin were observed with INVEGA i
Eintrag öffnenInvega · 4.8 · In adolescents, weight gain should be assessed against that expected with normal growth.
Eintrag öffnenInvega · 4.8 · In schizoaffective disorder clinical trials, a higher percentage of INVEGA-treated subjects (5%) had an increa
Eintrag öffnenInvega · 4.8 · In the schizoaffective disorder studies, a greater proportion of subjects in the total INVEGA dose group who w
Eintrag öffnenInvega · 4.8 · Paediatric population Summary of the safety profile In one short-term and two longer-term studies with paliper
Eintrag öffnenInvega · 4.8 · Paliperidone is the active metabolite of risperidone. The safety profile of risperidone may be pertinent.
Eintrag öffnenInvega · 4.8 · Prolactin In the up to 2-year, open-label treatment study of INVEGA in adolescents with schizophrenia, inciden
Eintrag öffnenInvega · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen